U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07268313) titled 'Complete Remission After Treatment With Biologics for Nasal Polyps' on Sept. 02.
Brief Summary: In this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.
Study Start Date: April 03
Study Type: INTERVENTIONAL
Condition:
Nasal Polyps
Intervention:
DRUG: DUPIXENT(R)
Continue Dupixent
DRUG: NUCALA(R)
"Continue Nucala
OTHER: Dupi discontinuation
Stop taking Dupixent at baseline; no substitute is given
OTHER: Mepo discontinuation
Stop taking Nucala at ...